In Vitro Diagnostics POC/Rapid diagnostics Global market Forecast to 2020 [Report Updated: 18082014] Prices from USD $4500

12:56 EDT 18 Aug 2017 | BioPortfolio Report Blog

In vitro diagnostics are tests that diagnose and prevent diseases, conditions or infections. IVD tests are performed outside body in an artificial environment on samples such as blood, urine, tissue isolated from human body. IVD is classified into 3 types namely: clinical laboratory testing, nearpatient testing, selftesting. IVD market is segmented bytechniques including immunoassays, point of care, molecular diagnostics, hematology, coagulation, microbiology, clinical techniques, microbiology, producttype including instruments, reagents, services, data management systems, usability including disposable, reusable, applications including diabetes, oncology, cardiology, HIV/AIDS, autoimmune disease, nephrology, drug testing, enduser including hospitals, laboratories, academics and geography globally.
The global IVD market was reported with high revenue in previous years and hence expected to grow at a high CAGR by 2019. The AsiaPacific and RoW regions are expected to register a significant growth rate for the IVD market. North America commands the largest share while Asia Pacific is the fastest revenue growing region.
IVD market growth is driven by factors such as increase in incidences of chronic and infectious diseases across all age cohorts, genetic diseases, aging population, rising acceptance of personalized medicine, rise in healthcare awareness in patients and high unmet medical needs in diagnosing diseases. Screening initiatives and high investment in healthcare infrastructures mainly contributes to market growth. Whereas, difficulty in rendering rapid diagnostic results, stringent regulatory policies, reimbursement issues and economic crisis are the major growth restraints. Different geographies is an opportunistic factor which improved IVD market growth.
Roche diagnostics Basel, Switzerland is expected to be the largest player in the IVD market, followed by Siemens and Abbott. The IVD market is highly consolidated, with the major players holding close to 80% market share. Top ten major players are Roche Diagnostics, Siemens HealthcareErlangen, Germany, AbbottAbbott Park, Illinois, Johnson and JohnsonNew Jersey, Beckman CoulterMassachusetts, Becton DickinsonU.S., bioMerieux France, Bayer DiabetesGermany, Sysmex U.S. and BioRadCalifornia. Key players such as Thermo Fisher Scientific, Inc., QIAGEN N.V., and ARKRAY, Inc. have established new manufacturing facilities and RD units in China to grow IVD market.
The focus of this research report description was on various levels of analysis, industry, market shares, value chain, PESTEL analysis and company profiles which together comprise and augment about competitive landscape, emerging and high growth segments of in vitro diagnostic molecular diagnostics point of care testing, emerging technologies.

The report provides an in depth market analysis of the above mentioned segments across the following regions:
North America
Rest of the World RoW

Original Article: In Vitro Diagnostics POC/Rapid diagnostics Global market Forecast to 2020 [Report Updated: 18082014] Prices from USD $4500


More From BioPortfolio on "In Vitro Diagnostics POC/Rapid diagnostics Global market Forecast to 2020 [Report Updated: 18082014] Prices from USD $4500"

Quick Search


Relevant Topic

A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...